Skip to content
Active InsightsAsset allocationBDC ETFEquityExchange-traded fundsFixed incomeGlobal sectorInternationalLarge Cap ValueMacroeconomicsOutlookSustainable investing   Search

Putnam Investments Putnam Perspectives

More from Putnam
Blogs
Advisor Tech Tips Wealth Management
Sites
Financial Advisors Individual Investors DC Investment Only Institutional Investors
  • Asset allocation
  • Equity
  • Fixed income
  • Global sector
  • International
  • Large Cap Value
  • Macroeconomics
  • Outlook
  • Sustainable investing

Tag: Putnam Global Health Care Fund

Health-care investing: What is the prognosis for emerging markets?
Equity Global sector International Outlook

Health-care investing: What is the prognosis for emerging markets?

Over the next 10 years, some of the greatest growth in health-care spending is projected for emerging markets such as China, India, and Brazil. For many reasons, growth opportunities are abundant in developing economies, but selecting health-care stocks, particularly among the smaller-cap companies based in these regions, is not without its challenges.

Does the Novartis acquisition foretell greater M&A activity for pharmaceutical stocks?
Equity Global sector International

Does the Novartis acquisition foretell greater M&A activity for pharmaceutical stocks?

Swiss pharmaceutical firm Novartis’s pending bid to acquire majority ownership of Alcon, an eye care products maker, in a deal valued at about $40 billion, stood out against a backdrop of only 3% mergers-and-acquisitions growth across industry sectors globally for the first half of 2010. While we aren’t likely to see many more large-scale mergers,

Putnam Investments
Follow us

Any Putnam funds referenced in the above articles are not available for sale outside the United States.

Services provided by Putnam may not be available in all countries or to all investors. This content is not an offer to any investor who is not qualified under local law.

The views and opinions expressed are those of the fund manager above, are subject to change with market conditions, and are not meant as investment advice.

This material is for informational and educational purposes only. It is not a recommendation of any specific investment product, strategy, or decision, and is not intended to suggest taking or refraining from any course of action. It is not intended to address the needs, circumstances, and objectives of any specific investor. Putnam, which earns fees when clients select its products and services, is not offering impartial advice in a fiduciary capacity in providing this sales and marketing material. This information is not meant as tax or legal advice. Investors should consult a professional advisor before making investment and financial decisions and for more information on tax rules and other laws, which are complex and subject to change.

All funds and investment products involve risk, and you can lose money. See the prospectus for details. Any economic and performance information is historical and not indicative of future results.

If you are a U.S. retail investor: Investors should carefully consider the investment objectives, risks, charges, and expenses of a fund before investing. For a prospectus, or a summary prospectus if available, containing this and other information for any Putnam fund or product, contact your financial representative, call Putnam at 1-888-4-PUTNAM (1-888-478-8626), or click on the prospectus section to view or download a prospectus. Please read the prospectus carefully before investing.

A Member of the Power Financial Corporation Group of Companies™

In the United States, mutual funds are distributed by Putnam Retail Management.

Top